Delivering rhFGF-18 via a bilayer collagen membrane to enhance microfracture treatment of chondral defects in a large animal model

ABSTRACT Augmented microfracture techniques use growth factors, cells, and/or scaffolds to enhance the healing of microfracture‐treated cartilage defects. This study investigates the effect of delivering recombinant human fibroblastic growth factor 18 (rhFHF18, Sprifermin) via a collagen membrane on...

Full description

Saved in:
Bibliographic Details
Published inJournal of orthopaedic research Vol. 33; no. 8; pp. 1120 - 1127
Main Authors Howard, Daniel, Wardale, John, Guehring, Hans, Henson, Frances
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.08.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ABSTRACT Augmented microfracture techniques use growth factors, cells, and/or scaffolds to enhance the healing of microfracture‐treated cartilage defects. This study investigates the effect of delivering recombinant human fibroblastic growth factor 18 (rhFHF18, Sprifermin) via a collagen membrane on the healing of a chondral defect treated with microfracture in an ovine model. Eight millimeter diameter chondral defects were created in the medial femoral condyle of 40 sheep (n = 5/treatment group). Defects were treated with microfracture alone, microfracture + intra‐articular rhFGF‐18 or microfracture + rhFGF‐18 delivered on a membrane. Outcome measures included mechanical testing, weight bearing, International Cartilage Repair Society repair score, modified O'Driscoll score, qualitative histology, and immunohistochemistry for types I and II collagen. In animals treated with 32 μg rhFGF‐18 + membrane and intra‐articularly, there was a statistically significant improvement in weight bearing at 2 and 4 weeks post surgery and in the modified O'Driscoll score compared to controls. In addition, repair tissue stained was more strongly stained for type II collagen than for type I collagen. rhFGF‐18 delivered via a collagen membrane at the point of surgery potentiates the healing of a microfracture treated cartilage defect. © 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 33:1120–1127, 2015.
Bibliography:istex:F1476D898620EA83132F50BBF833767CFF2CCE9B
ArticleID:JOR22882
ark:/67375/WNG-2M5PZ7V8-S
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0736-0266
1554-527X
DOI:10.1002/jor.22882